Notify me when Patient Square Capital LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 28 | $467,131,666 | +$119,975,584 | -$146,641,421 | -$26,665,837 | ROIV, INSM, MIRM, ARGX, ONC | 13F-HR | 12 Feb 2026, 10:05 |
| Q3 2025 | 24 | $373,857,431 | +$50,967,660 | -$50,893,496 | +$74,164 | ROIV, INSM, EYPT, ABVX, CDTX | 13F-HR | 10 Nov 2025, 13:23 |
| Q2 2025 | 19 | $277,387,742 | +$20,999,362 | -$16,194,689 | +$4,804,673 | ROIV, INSM, ARGX, EYPT, LQDA | 13F-HR | 11 Aug 2025, 17:01 |
| Q1 2025 | 19 | $241,723,318 | +$25,160,788 | -$21,639,089 | +$3,521,699 | ROIV, INSM, LQDA, EYPT, OCUL | 13F-HR | 14 May 2025, 15:37 |
| Q4 2024 | 20 | $267,374,731 | +$52,769,748 | -$63,254,541 | -$10,484,793 | ROIV, LQDA, INSM, CGEM, EYPT | 13F-HR | 14 Feb 2025, 09:30 |
| Q3 2024 | 11 | $269,410,777 | +$56,468,971 | $0 | +$56,468,971 | ROIV, LQDA, CGEM, INSM, EYPT | 13F-HR | 14 Nov 2024, 16:11 |
| Q2 2024 | 2 | $215,445,259 | $0 | $0 | $0 | ROIV, LQDA | 13F-HR | 13 Aug 2024, 07:01 |
| Q1 2024 | 2 | $234,830,368 | +$105,942,347 | -$45,313,900 | +$60,628,447 | ROIV, LQDA | 13F-HR | 14 May 2024, 16:22 |
| Q4 2023 | 2 | $182,923,466 | $0 | $0 | $0 | ROIV, EAR | 13F-HR | 13 Feb 2024, 16:06 |
| Q3 2023 | 2 | $181,982,306 | $0 | $0 | $0 | ROIV, EAR | 13F-HR | 14 Nov 2023, 09:21 |
| Q2 2023 | 2 | $205,409,398 | +$58,604,646 | $0 | +$58,604,646 | ROIV, EAR | 13F-HR | 11 Aug 2023, 16:06 |
| Q1 2023 | 2 | $124,419,315 | +$74,043,679 | -$181,944,939 | -$107,901,260 | EAR, ROIV | 13F-HR | 10 May 2023, 06:15 |
| Q4 2022 | 2 | $236,484,415 | $0 | $0 | $0 | EAR, ROIV | 13F-HR | 13 Feb 2023, 15:17 |